Talazoparib Maintenance Therapy in Triple-negative Breast Cancer

NCT04755868 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

206

Enrollment

OTHER

Sponsor class

Conditions

TNBC - Triple-Negative Breast Cancer

Interventions

DRUG: Talazoparib
DRUG: Placebo

Sponsor

Yonsei University